Published in Fertil Steril on March 19, 2010
Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome. Fertil Steril (2013) 2.63
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol (2014) 1.41
Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 1.01
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med (2012) 0.98
Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab (2013) 0.89
Obesity differentially affects phenotypes of polycystic ovary syndrome. Int J Endocrinol (2012) 0.85
Associations of estrogen and testosterone with insulin resistance in pre- and postmenopausal women with and without hormone therapy. Int J Endocrinol Metab (2013) 0.84
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome? Front Endocrinol (Lausanne) (2012) 0.83
Association of TRB3 Q84R polymorphism with polycystic ovary syndrome in Chinese women. Reprod Biol Endocrinol (2011) 0.80
A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Reprod Health (2015) 0.78
Health related quality of life among different PCOS phenotypes of infertile women. J Turk Ger Gynecol Assoc (2012) 0.77
Western-style diet, with and without chronic androgen treatment, alters the number, structure, and function of small antral follicles in ovaries of young adult monkeys. Fertil Steril (2015) 0.75
Correlation between the serum luteinizing hormone to folliclestimulating hormone ratio and the anti-Müllerian hormone levels in normo-ovulatory women. J Korean Med Sci (2015) 0.75
Polycystic Ovary Syndrome May Be an Autoimmune Disorder. Scientifica (Cairo) (2016) 0.75
Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome. J Turk Ger Gynecol Assoc (2016) 0.75
Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome. Oman Med J (2017) 0.75
Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes. Sci Rep (2017) 0.75
Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study. Fertil Res Pract (2017) 0.75
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update (2013) 1.81
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 1.44
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? Am J Obstet Gynecol (2008) 1.43
Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone (2006) 1.18
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril (2011) 1.01
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod (2009) 0.99
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 0.95
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am J Obstet Gynecol (2006) 0.92
Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab (2013) 0.90
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. Clin Endocrinol (Oxf) (2007) 0.87
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome. Hum Reprod (2005) 0.85
Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Fertil Steril (2008) 0.83
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study. Hum Reprod (2006) 0.83
Not all women diagnosed with PCOS share the same cardiovascular risk profiles. Fertil Steril (2009) 0.83
Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat. Int J Gynaecol Obstet (2008) 0.81
AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES. Endocr Pract (2015) 0.80
Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome. Fertil Steril (2008) 0.78
Need for liver evaluation in polycystic ovary syndrome. J Hepatol (2007) 0.77
Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Fertil Steril (2005) 0.77
Androgen disorders. Steroids (2011) 0.75
The spectrum of androgen excess disorders. Fertil Steril (2006) 0.75
Introduction to the special issue: 2012 AE-PCOS meeting. Steroids (2013) 0.75
Advances in the Diagnosis and Treatment of PCOS. Curr Pharm Des (2016) 0.75
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms. Fertil Steril (2009) 0.75